Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, announced the publication of a pivotal study in Science describing a major advancement in cancer research — the discovery and preclinical validation of small-molecule covalent inhibitors…
Genethon, a global pioneer in gene therapy research and development for rare genetic diseases, has announced compelling long-term efficacy results from its micro-dystrophin gene therapy (GNT0004) for Duchenne muscular dystrophy (DMD). The data, presented at the 32nd Annual Congress of…
A new clinical study from Citruslabs, a leading independent research organization, has found that Droptics, an innovative eye drop designed specifically for the digital age, provides significant relief for people suffering from screen-induced eye strain, dryness, and fatigue. As modern…
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company focused on developing transformative gene therapies for rare neurological diseases, has announced a key regulatory update for its NGN-401 gene therapy in Rett syndrome. The company completed discussions with the U.S. Food…
The Institute of Clinical Research (The ICR) has announced the launch of its Company Membership Scheme, a strategic initiative aimed at strengthening professional development, collaboration, and engagement across the clinical research sector. The program is designed to broaden access to…
Charles River Laboratories International, Inc. and Toxys have announced a strategic collaboration to expand access to ReproTracker®, a cutting-edge, human stem cell-based in vitro assay designed to identify developmental toxicity hazards in pharmaceuticals and chemicals. The partnership aims to accelerate…
The IMA Group (IMA), a leading national provider of medical and psychological evaluations and clinical research services, has announced the acquisition of Chicago Research Center (CRC), an independent, Chicago-based clinical research site with a strong reputation in central nervous system…
Kernal Biologics, Inc., a venture-backed TechBio company transforming the treatment landscape through mRNA-based in vivo cell programming, announced it has been awarded up to $48 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). The award comes…
Hesperos, Inc., a global leader in developing Human-on-a-Chip® (HoaC) technology for improving preclinical testing across pharmaceuticals, food, cosmetics, and chemicals, has announced a groundbreaking advancement in neuroscience research. In collaboration with Bayer Consumer Health, the company has unveiled the first…
Seek Labs, a biotechnology company at the forefront of AI-driven drug discovery and programmable therapeutics, has announced major progress in the development of what could become the world’s first pan-orthopoxvirus therapeutic. This next-generation treatment aims to provide broad protection against…